Young stroke and basal plasma and post-methionine load homocysteine and cysteine levels 1 year after the acute event: do plasma folates make the difference?

被引:8
作者
Beccia, M
Mele, MC
Ferrari, M
Ranieri, M
Barini, A
Rasura, M
机构
[1] Univ Roma La Sapienza, Fac Med 2, Dept Neurol Sci, Rome, Italy
[2] Univ Sacred Heart, Inst Biochem & Clin Biochem, I-00168 Rome, Italy
关键词
folate; homocysteine; methionine; stroke; young;
D O I
10.1046/j.1468-1331.2003.00774.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We conducted a case-control Study to evaluate the relationship between ischemic stroke in young adults (<45 years of age) and plasma homocysteine (Hcy), plasma folate and vitamin B-12, after a methionine load. We studied 42 patients with a history of ischemic stroke and 29 controls with a negative clinical history of cardio- or cerebrovascular diseases, venous thrombosis and renal disease. A fasting blood sample was drawn from each participant; the second and third samples were collected, respectively, 120 and 240 min after the methionine load. Whilst there was no difference between controls and patients in basal total homocysteine (tHcy), we found a statistically significant difference in both the 120- and 240-min samples. We compared the basal and 240-min tHcy in patients and controls. We obtained a median value of 17.8 and 11.6 μmol/l in patients and controls, respectively. The difference between these two values was highly significant. The methionine loading test (MLT) reveals Hey metabolism abnormalities that were not revealed by the basal sample. MLT may help identify and treat this new risk factor, which seems to be both atherogenic and prothrombotic, and is hypothesized to operate through various mechanisms.
引用
收藏
页码:269 / 275
页数:7
相关论文
共 54 条
[11]  
CHANARIN I, 1985, LANCET, V2, P1168
[12]   ELEVATED PLASMA HOMOCYST(E)INE CONCENTRATION AS A POSSIBLE INDEPENDENT RISK FACTOR FOR STROKE [J].
COULL, BM ;
MALINOW, MR ;
BEAMER, N ;
SEXTON, G ;
NORDT, F ;
DEGARMO, P .
STROKE, 1990, 21 (04) :572-576
[13]   HUMAN ARTERIAL ENDOTHELIAL-CELL DETACHMENT INVITRO - ITS PROMOTION BY HOMOCYSTEINE AND CYSTEINE [J].
DUDMAN, NPB ;
HICKS, C ;
WANG, J ;
WILCKEN, DEL .
ATHEROSCLEROSIS, 1991, 91 (1-2) :77-83
[14]   Plasma homocysteine as a risk factor for vascular disease - The European concerted action project [J].
Graham, IM ;
Daly, LE ;
Refsum, HM ;
Robinson, K ;
Brattstrom, LE ;
Ueland, PM ;
PalmaReis, RJ ;
Boers, GHJ ;
Sheahan, RG ;
Israelsson, B ;
Uiterwaal, CS ;
Meleady, R ;
McMaster, D ;
Verhoef, P ;
Witteman, J ;
Rubba, P ;
Bellet, H ;
Wautrecht, JC ;
deValk, HW ;
Luis, ACS ;
ParrotRoulaud, FM ;
Tan, KS ;
Higgins, I ;
Garcon, D ;
Medrano, MJ ;
Candito, M ;
Evans, AE ;
Andria, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (22) :1775-1781
[15]   PLASMA-CONCENTRATIONS OF HOMOCYSTEINE AND OTHER AMINOTHIOL COMPOUNDS ARE RELATED TO FOOD-INTAKE IN HEALTHY-HUMAN SUBJECTS [J].
GUTTORMSEN, AB ;
SCHNEEDE, J ;
FISKERSTRAND, T ;
UELAND, PM ;
REFSUM, HM .
JOURNAL OF NUTRITION, 1994, 124 (10) :1934-1941
[16]   What level of plasma homocyst(e)ine should be treated?: Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 μmol/L [J].
Hackam, DG ;
Peterson, JC ;
Spence, JD .
AMERICAN JOURNAL OF HYPERTENSION, 2000, 13 (01) :105-110
[17]   Homocysteine and vascular disease [J].
Hankey, GJ ;
Eikelboom, JW .
LANCET, 1999, 354 (9176) :407-413
[18]   Homocysteine and stroke [J].
Hankey, GJ ;
Eikelboom, JW .
CURRENT OPINION IN NEUROLOGY, 2001, 14 (01) :95-102
[19]   Cellular and molecular mechanisms of endothelial cell dysfunction [J].
Harrison, DG .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) :2153-2157
[20]   CEREBRAL INFARCTION IN YOUNG-ADULTS - A PRACTICAL APPROACH [J].
HART, RG ;
MILLER, VT .
STROKE, 1983, 14 (01) :110-114